Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/09/2878422/0/en/Press-release-Biocartis-Group-NV-Biocartis-Group-NV-provides-an-update-regarding-the-publication-of-its-annual-report-and-the-annual-meeting.html
https://www.pharmiweb.com/press-release/2024-05-07/biocartis-and-merck-to-collaborate-on-improving-patient-access-to-personalized-medicine-in-middle-east-and-north-africa-mea-region
https://www.globenewswire.com/news-release/2024/05/06/2875506/0/en/Press-Release-Biocartis-NV-Biocartis-and-Merck-to-Collaborate-on-Improving-Patient-Access-to-Personalized-Medicine-in-Middle-East-and-North-Africa-MEA-Region.html
https://www.globenewswire.com//news-release/2024/01/10/2807542/0/en/Press-release-Biocartis-Group-NV-Disclosure-of-transparency-notification-Article-14-first-paragraph-of-the-Act-of-2-May-2007-on-the-disclosure-of-major-shareholdings.html
https://www.globenewswire.com//news-release/2023/11/22/2784601/0/en/Press-release-Biocartis-Holdings-Inc-Recapitalization-completed-and-product-portfolio-expansion.html
https://www.globenewswire.com//news-release/2023/11/13/2778676/0/en/Press-release-Biocartis-NV-Biocartis-Hosts-Corporate-Workshop-and-Announces-Seven-Idylla-Abstracts-to-be-Presented-at-AMP-2023-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/10/31/2770414/0/en/Press-release-Biocartis-Group-NV-Announcement-regarding-Enforcement-by-Secured-Creditors.html
https://www.globenewswire.com//news-release/2023/10/20/2763794/0/en/Press-release-Biocartis-Group-NV-Four-Abstracts-Showing-Excellent-Data-for-Idylla-Presented-at-European-Society-of-Molecular-Oncology-Congress-ESMO.html
https://www.globenewswire.com//news-release/2023/10/16/2760280/0/en/Press-release-Biocartis-Group-NV-Biocartis-Honors-Breast-Cancer-Awareness-Month-with-Launch-of-Breast-Cancer-Portfolio.html
https://www.globenewswire.com//news-release/2023/10/12/2758918/0/en/Press-release-Biocartis-Group-NV-Biocartis-Announces-Expansion-of-its-Collaboration-with-APIS-Assay-Technologies-to-Commercialize-the-APIS-ESR1-Mutations-Kit.html